Harvon(ledipasvir and sofosbuvir) Hepatitis C New Drug Get FDA Approval

Harvon(ledipasvir and sofosbuvir) Hepatitis C New Drug Get FDA Approval

The U.S. Food and Drug Administration today approved Harvoni (ledipasvir and sofosbuvir) to treat chronic hepatitis C virus (HCV) genotype 1 infection.Harvoni (ledipasvir and sofosbuvir) is a once-daily NS5A inhibitor and nucleotide an...

Close